Guerbet SA
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solut… Read more
Guerbet SA (4G8) - Total Liabilities
Latest total liabilities as of December 2024: €645.68 Million EUR
Based on the latest financial reports, Guerbet SA (4G8) has total liabilities worth €645.68 Million EUR as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Guerbet SA - Total Liabilities Trend (2013–2024)
This chart illustrates how Guerbet SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Guerbet SA Competitors by Total Liabilities
The table below lists competitors of Guerbet SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
IMSNF
PINK:IMSNF
|
USA | $22.47 Billion |
|
8098
TWO:8098
|
Taiwan | NT$273.30 Million |
|
Elanor Investors Group
AU:ENN
|
Australia | AU$619.30 Million |
|
Ratchaphruek Hospital Public Company Limited
BK:RPH
|
Thailand | ฿208.10 Million |
|
Holiday Entertainment Co Ltd
TW:9943
|
Taiwan | NT$1.56 Billion |
|
Yulon Nissan Motor Co Ltd
TW:2227
|
Taiwan | NT$4.74 Billion |
|
Sugentech Inc
KQ:253840
|
Korea | ₩20.68 Billion |
|
Lingotes
MC:LGT
|
Spain | €56.71 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Guerbet SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.64 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guerbet SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guerbet SA (2013–2024)
The table below shows the annual total liabilities of Guerbet SA from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €645.68 Million | -0.20% |
| 2023-12-31 | €646.97 Million | +15.52% |
| 2022-12-31 | €560.07 Million | -5.99% |
| 2021-12-31 | €595.74 Million | +2.47% |
| 2020-12-31 | €581.40 Million | -6.18% |
| 2019-12-31 | €619.67 Million | -13.22% |
| 2018-12-31 | €714.05 Million | +16.78% |
| 2017-12-31 | €611.45 Million | -14.28% |
| 2016-12-31 | €713.35 Million | +15.05% |
| 2015-12-31 | €620.06 Million | +186.36% |
| 2014-12-31 | €216.53 Million | -2.15% |
| 2013-12-31 | €221.29 Million | -- |